1 result(s) for
| PI Name | Protocol # | Title |
|---|---|---|
| Jeremy Cetnar | STUDY00021770 | [NCI CIRB] EA5191: A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC |
You may also qualify for Phase 1 Program trials.